EU considers new criteria for China during EV tariff negotiations
The European Union (EU) might require China to transfer intellectual property (IP) for clean technologies. The move comes as the EU and China continue negotiations over the latter’s tariffs on Chinese electric vehicle (EV) imports.
Last month, enough EU member states voted to impose higher tariffs on China-made EV imports. However, the EU still needs to finalize its tariff rates for Chinese EV imports. Both countries have been discussing other avenues to settle the disagreement between them.
According to the Financial Times, the EU plans to require Chinese companies to transfer intellectual property to European businesses. The exchange would be part of the EU’s subsidy schemes.
The EU might impose new criteria, requiring Chinese businesses to build factories in Europe and share IP related to clean technology. The new criteria is expected to launch when the EU invites bids for €1 billion worth of grants to develop batteries. Bids for the grants are scheduled to start in December.
The EU’s criteria for transferring IP would not be a foreign concept to China. The Chinese government imposes similar requirements on foreign companies seeking access to the Chinese market.
The Teslarati team would appreciate hearing from you. If you have any tips, contact me at [email protected] or via Twitter @Writer_01001101.
The post EU considers new criteria for China during EV tariff negotiations appeared first on TESLARATI.
Source: https://www.teslarati.com/eu-china-ev-tariff-negotiations-ip-transfer/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.